Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ayako Nasu is active.

Publication


Featured researches published by Ayako Nasu.


Carbohydrate Research | 1998

New enzymatic synthesis of 63-modified maltooligosaccharides and their inhibitory activities for human α-amylases

Riichiro Uchida; Ayako Nasu; Shoichi Tokutake; Kouichi Kasai; Koichiro Tobe; Nobuyuki Yamaji

Ten new 6(3)-modified maltopentaoses and tetraoses were synthesized by enzymatic reactions utilizing cyclodextrin glycosyltransferase (EC 2.4.1.19) and subsequent human salivary alpha-amylase (HSA) (EC 3.2.1.1). Among these compounds, alpha-D-glucopyranosyl-(1-->4)- alpha-D-glucopyranosyl-(1-->4)-(6-deoxy-alpha-D-glucopyranosyl)-(1-->4)- alpha-D-glucopyranosyl-(1-->4)-D-glucopyranose (11) and alpha-D-glucopyranosyl-(1-->4)-(6-deoxy-alpha-D-glucopyranosyl)-(1-->4)- alpha-D-glucopyranosyl-(1-->4)-D-glucopyranose (12) showed strong inhibitory activities for human pancreatic alpha-amylase (HPA) and HSA. The IC50 of 6(3)-deoxymaltopentaose 11 (8.0 x 10(-5) M for HPA, 1.0 x 10(-4) M for HSA) and 6(3)-deoxymaltotetraose 12 (2.0 x 10(-3) M for HPA, 2.0 x 10(-3) M for HSA) were lower than that of 6(3)-deoxymaltotriose [(6-deoxy-alpha-D-glucopyranosyl)-(1-->4)-alpha-D- glucopyranosyl-(1-->4)-D-glucopyranose 13; 2.0 x 10(-3) M for HPA, 4.2 x 10(-2) M for HSA].


Chemical & Pharmaceutical Bulletin | 1999

Synthesis of new N-containing maltooligosaccharides, α-amylase inhibitors, and their biological activities

Riichiro Uchida; Ayako Nasu; Shoichi Tokutake; Kouichi Kasai; Koichiro Tobe; Nobuyuki Yamaji


Archive | 2000

Malto-oligosaccharide derivatives and uses thereof

Riichiro Uchida; Ayako Nasu; Yukihiko Iwai; Takao Someya; Koichiro Tobe


Carbohydrate Research | 1996

A convenient preparation of maltooctaose and maltononaose by the coupling reaction of cyclomaltodextrinase

Riichiro Uchida; Ayako Nasu; Kouichiro Tobe; Tetsuya Oguma; Nobuyuki Yamaji


Chemical & Pharmaceutical Bulletin | 1997

An Efficient Preparation of Acetyl Isoflavone Glucoside

Toru Izumi; Ayako Nasu; Shigehiro Kataoka; Shoichi Tokutake; Akio Obata; Koichiro Tobe


Archive | 1985

Process for preparation of N6-substituted 3',5'-cyclic adenosine monophosphate and salt thereof

Shigehiro Kataoka; Ayako Nasu; Nobuyuki Yamaji; Motohiko Kato


Journal of pharmacobio-dynamics | 1992

Effect of adenosine 3',5'-cyclic monophosphate derivatives on acute liver injury induced by carbon tetrachloride

Makoto Saito; Ayako Nasu; Shigehiro Kataoka; Nobuyuki Yamaji; Atsushi Ichikawa


Journal of pharmacobio-dynamics | 1989

Cytotoxic Effect of 8-Amino Adenosine 3', 5'-Cyclic Monophosphate on FM3A Mouse Mammary Tumor Cells

Makoto Saito; Ayako Nasu; Shigehiro Kataoka; Katsunori Ohshita; Nobuyuki Yamaji


Archive | 1996

Malto-oligosaccharide derivative, and production and use of the same

Mamoru Kikuchi; Katsuko Matsuura; Ayako Nasu; Riichiro Uchida; Jun Yamakoshi; Nobuyuki Yamatsugu; 理一郎 内田; 信幸 山次; 純 山越; 克子 松浦; 護 菊地; 綾子 那須


Chemical & Pharmaceutical Bulletin | 1991

Studies on the Synthesis of COmpounds Related to Adenosine 3', 5'-Cyclic Phosphate. IX. Synthesis and Cytotoxic Effect of Adenosine 3', 5'-Cyclic Alkylphosphoramidates

Makoto Saito; Shigehiro Kataoka; Ayako Nasu; Nobuyuki Yamaji; Atsushi Ichikawa

Collaboration


Dive into the Ayako Nasu's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge